Drugs in Development: From Pipeline to Market 2011

PharmaLive Special Reports
July 1, 2011
102 Pages - SKU: ENPP6526280
License type:
Countries covered: United States

In this annual compilation, PharmaLive analysts detail information about prescription medicines in clinical development as well as those approved for marketing in the United States during the period June 2010 through May 2011.

Drugs are organized by their approved or development status. Each section provides:
  • Commercial name or product code
  • Chemical or substance composition
  • Approved or intended indication
  • Developer with company Website



Additional Information

Also included in this report:
  • Top R&D spenders of 2010, and the number of drugs in development by therapeutic category
  • Comprehensive listing of companies and the therapeutic categories in which they are developing
  • Comparison of 2010-2011 top ten therapeutic categories against 2009-2010
  • Alphabetical listing of drugs in development, including their therapeutic area

More United States Clinical Trial Reports

Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US by GBI Research
Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US Summary GBI Research, the leading business intelligence provider, has ...

Phase IV Clinical Trials by Cutting Edge Information
Whether building a better product profile, establishing comparative effectiveness or accomplishing any number of other objectives, post-marketing research grants companies a range of clinical and ...

Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development by GBI Research
Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development Summary GBI Research has released ...

Outsourcing in Clinical Trials New Jersey by Arena International
Synopsis The proceedings from VIB Pharma's 2010 Outsourcing in Clinical Trials New Jersey conference Summary VIBpharma delivered cutting edge conference content for professionals in pharmaceutical and biotech manufacturers ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>